News
Explore the latest stories and publications from NCATS and our partners, see upcoming events, or explore the variety of resources we provide to better understand translational science and our work.
News
Read the latest news from NCATS and its collaborators whose research is supported through the Center’s programs, or follow coverage of NCATS' translational research activities through national and local media.
NCATS Enables a Drug’s Path to FDA Approval for Duchenne Muscular Dystrophy
March 15, 2024 - NCATS News
- Our Impact on Drug Discovery and Development
- Our Impact on Rare Diseases
- Therapeutics for Rare and Neglected Diseases (TRND)
NCATS scientists conducted laboratory studies and provided guidance in the development of a drug for the rare muscle disease Duchenne muscular dystrophy.
Eliminating Socioeconomic Disparities in Youth Physical Activity Can Save Over $15 Billion
March 15, 2024 - Grantee/Partner News
- Clinical and Translational Science Awards (CTSA) Program
Updates on CDC’s New Respiratory Virus Guidance, COVID Antivirals & the Emergence of Clade I Mpox
March 15, 2024 - Grantee/Partner News
- Antiviral Program for Pandemics (APP)
Study Finds Higher Risk for Fracture From Falls in Men Than in Women
March 12, 2024 - Grantee/Partner News
- Clinical and Translational Science Awards (CTSA) Program
Health Professionals and Laypeople Feel Differently About Allocating Scarce Lifesaving Resources in a Crisis
March 12, 2024 - Grantee/Partner News
- Clinical and Translational Science Awards (CTSA) Program
Sugar Compound’s Key Role in SARS-CoV-2 Infection May Lead to New COVID-19 Therapies
March 11, 2024 - NCATS News
A research team led by NCATS scientists found new clues about how SARS-CoV-2, the virus that causes COVID-19, can infect cells. This could lead to new treatments to block viral infection.
Sharing Science and Stories at Rare Disease Day Symposium
March 7, 2024 - Grantee/Partner News
- Our Impact on Rare Diseases
P.J. Brooks, Ph.D., on Working to Bring Gene Therapy Development to More Neuromuscular Disorders
March 5, 2024 - Media Coverage
- Bespoke Gene Therapy Consortium (BGTC)
- Platform Vector Gene Therapy (PaVe-GT)